RPS6KB1 and Hypercholesterolemia: In a study by Benslama et al. [20], hypercholesterolemia was associated with longer PFS, whereas the presence of bone metastases and overexpression of phosphorylated p70S6 kinase (p-p70S6K) by tumor cells were associated with shorter PFS under everolimus.